About Monopharma
Monopharma is a Healthcare company. It operates as a pharmaceutical marketing and distribution of medical products in India. Its Indian entity Monopharma Private Limited reported revenue of ₹1.63 Cr. Monopharma offers products and services including Tablets and Capsules. Its focus areas include Medical Services, Gynaecological Care, Women's Health Products and Pharmaceuticals.
Company details
Monopharma Is Identified As An Ethics-driven Pharmaceutical Marketing Organization That Was Established In 2019. Products Are Supplied Through Collaborations With Certified Indian Manufacturers, Ensuring Compliance With Standards Like Usfda, Who, And Gmp. Rigorous Quality Checks Are Conducted Across Manufacturing, Distribution, And Storage Processes To Maintain Innovation And Affordability In Chronic And Acute Therapy Segments. A Variety Of Items, Including Tablets And Capsules, Are Made Available For Medical And Gynaecological Care, With A Focus On Accessibility And Continuous Improvement.
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Legal Name Monopharma Pvt Ltd
- Date of Incorporation 16 Nov, 2019
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹1.63 Cr
FY 2025 · +4% YoY
- Net Profit₹7.1 Lakh
FY 2025 · 4% margin
- EBITDA₹11 Lakh
FY 2025 · 7% margin
Associated legal entities of Monopharma
Monopharma operates through Monopharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Monopharma Private Limited CIN U51397GJ2019PTC110832 | Active | 16 Nov 2019 | Ahmedabad, Gujarat | ₹1.6 Cr | – | 2 | View details |
Products & Services of Monopharma
Monopharma offers a comprehensive portfolio of products and services, including Tablets and Capsules.
Tablets are provided for various healthcare applications, ensuring effective treatment in medical scenarios.
Capsules are offered for precise dosing in healthcare, supporting treatments in gynaecological and general care.
Board of directors of Monopharma Private Limited (Monopharma)
Monopharma Private Limited is the primary company behind Monopharma. The board of Monopharma Private Limited currently have 2 directors; the longest-serving is Salim Mansuri, appointed in 2019. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Salim Mansuri DIN 08613106 | Director | 16 Nov 2019 | 6 yrs 11 mo | Monopharma Private Limited |
| Vipin Kumar Mehra DIN 08613108 | Director | 16 Nov 2019 | 6 yrs 11 mo | Monopharma Private Limited |
Financials of Monopharma
Figures of Monopharma Private Limited, the primary company behind Monopharma, for FY 2025. Revenue was ₹1.63 Cr (+4% year on year). Net profit was ₹7.1 Lakh (4% margin). EBITDA was ₹11 Lakh (7% margin). Revenue has grown at a compounded annual rate of +32% over three years.
- ₹1.63 CrRevenue · FY 2025 · +4% YoY
- ₹7.1 LakhNet profit · 4% margin
- ₹11 LakhEBITDA · 7% margin
- ₹1 LakhPaid-up capital
- +32%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Monopharma Private Limited are on its company page.
Detailed financial statements for Monopharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Women's Health & Fertility
10 companies that operate in the same segment as Monopharma (Women's Health & Fertility), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Internet first brand offering wearable breast pumps | 2013 | London, England, United Kingdom | USD 157.63 M | – | – | |
Silicone-filled breast and body shaping implants are designed and manufactured. | 2010 | Alajuela, Alajuela, Costa Rica | USD 121 M | USD 211.08 M | 1,020 | |
Immunotherapeutics for cancer and other diseases are developed. | 2008 | Mainz, Rhineland-palatinate, Germany | USD 805.99 M | USD 3.24 B | 6,770 | |
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 123.06 M | USD 19.59 M | – | |
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | – | 861 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Platform for breast ultrasound imaging | 2010 | Plymouth, Massachusetts, United States | USD 136.54 M | – | – | |
Silicone breast implants are developed for reconstruction and aesthetic surgery. | 2007 | Dublin, Ireland | USD 232.81 M | – | – | |
A minimally invasive ablation system for uterine fibroids is developed. | 2005 | Redwood City, California, United States | USD 282.54 M | – | 92 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Monopharma
The primary company behind Monopharma, Monopharma Private Limited, reported revenue of ₹1.63 Cr for FY 2025, up 4% year on year.
Monopharma Is Identified As An Ethics-driven Pharmaceutical Marketing Organization That Was Established In 2019. Products Are Supplied Through Collaborations With Certified Indian Manufacturers, Ensuring Compliance With Standards Like Usfda, Who, And Gmp. Rigorous Quality Checks Are Conducted Across Manufacturing, Distribution, And Storage Processes To Maintain Innovation And Affordability In Chronic And Acute Therapy Segments. A Variety Of Items, Including Tablets And Capsules, Are Made Available For Medical And Gynaecological Care, With A Focus On Accessibility And Continuous Improvement.
Monopharma offers Tablets and Capsules.
Monopharma operates through Monopharma Private Limited.
The legal entities of Monopharma currently have 2 directors, including Salim Mansuri, Vipin Kumar Mehra.